ghk-cu peptide oral Instamed® Sublingual Peptides Oral Liposomal Copper GHK –

Much of the GHK-Cu literature comes from Loren Pickart, who both discovered the peptide and holds patents related to copper peptide skincare products

On the other hand, baseline measurements found that levels of IL-10 in APP/PS1 mice were significantly reduced in comparison to wild type mice, and when treated with Dihexa these mice experienced an increase in IL-10 levels

ADEPT-2: Cobenfy for Psychosis in Alzheimers Disease (Bristol Myers Squibb) ADEPT-2 is a Phase III trial evaluating Cobenfy (xanomeline/trospium) for hallucinations and delusions associated with Alzheimers disease

That said, some preclinical research has explored oral BPC-157 in the context of gastrointestinal health, where localized gut exposure may be relevant